- AU$97.16m
- AU$86.40m
- AU$0.48m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 8.25 | ||
Price to Tang. Book | 8.25 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 203.93 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -90.85% | ||
Return on Equity | -92.3% | ||
Operating Margin | -2253.72% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 0.11 | 0.12 | 0.12 | 0.32 | 0.48 | n/a | n/a | 28.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Elevate Uranium Ltd is an Australia-based uranium exploration company. The Company is engaged in the exploration and evaluation of its mineral tenements in Namibia and Australia and enhancing the value through the potential application of the Company’s patented U-pgrade uranium beneficiation process to those mineral tenements. Its Namibia tenements include Koppies, Hirabeb, Namib IV, Marenica Uranium Project, and Capri. The Company holds around ten active tenements in the Erongo Region of Namibia, each at varying stages of exploration advancement. The Koppies tenement (EPL 6987) is located in the Namib Desert region of Namibia. The Capri tenement (EPL 7508) is located in the Erongo uranium province in Namibia. In Australia, the Company's tenements consist of the 100% owned Angela, Thatcher Soak, Oobagooma and Minerva Projects and holdings in the Bigrlyi, Malawiri, Walbiri and Areva Joint Ventures. The Angela tenement (EL25758) is a sandstone-hosted roll-front type uranium deposit.
Directors
- Address
- Suite 2, 5 Ord Street, PERTH, 6005
- Web
- https://www.elevateuranium.com.au/
- Phone
- +61 865551816
- Auditors
- In.Corp Audit & Assurance Pty Ltd
Upcoming Events for EL8
Elevate Uranium Ltd Annual Shareholders Meeting
Half Year 2025 Elevate Uranium Ltd Earnings Release
Similar to EL8
Alligator Energy
Australian Stock Exchange - SEATS
Aura Energy
Australian Stock Exchange - SEATS
Aurora Energy Metals
Australian Stock Exchange - SEATS
Bannerman Energy
Australian Stock Exchange - SEATS
Basin Energy
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:26 UTC, shares in Elevate Uranium are trading at AU$0.32. This share price information is delayed by 15 minutes.
Shares in Elevate Uranium last closed at AU$0.32 and the price had moved by -30% over the past 365 days. In terms of relative price strength the Elevate Uranium share price has underperformed the ASX All Ordinaries Index by -40.23% over the past year.
There is no consensus recommendation for this security.
Find out moreElevate Uranium does not currently pay a dividend.
Elevate Uranium does not currently pay a dividend.
Elevate Uranium does not currently pay a dividend.
To buy shares in Elevate Uranium you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.32, shares in Elevate Uranium had a market capitalisation of AU$97.16m.
Here are the trading details for Elevate Uranium:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EL8
Based on an overall assessment of its quality, value and momentum Elevate Uranium is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elevate Uranium. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -42.47%.
As of the last closing price of AU$0.32, shares in Elevate Uranium were trading -28.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Elevate Uranium PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.32.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Elevate Uranium's management team is headed by:
- Andrew Bantock - CHM
- Murray Hill - CEO
- Shane McBride - CFO
- Stephen Mann - NED